Oliveira C Mario MD Palm Bay, FL - 32905

Oliveira C Mario MD is categorized under Internal Medicine Doctors in Palm Bay, FL and active since 1982.

Oliveira C Mario MD was established in 1982, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact C Mario Oliveira at the company’s single location by writing to 5200 Babcock St Ne # 101, Palm Bay, Florida FL 32905 or by phoning (321) 729-6166. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Oliveira C Mario MD
Contact Person: C Mario Oliveira
Address: 5200 Babcock St Ne # 101, Palm Bay, Florida 32905
Phone Number: (321) 729-6166
Website Address: healthfirstmedicalgroup.org
Annual Revenue (USD): $500.000 to $999.999
Founded: 1982
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Oliveira C Mario MD was started in 1982 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact C Mario Oliveira for inquiries that concern Oliveira C Mario MD by calling the company number (321) 729-6166, as your correspondence is most welcome. Additionally, the physical location of the single location of Oliveira C Mario MD can be found at the coordinates 28.02122,-80.62221 as well as the street address 5200 Babcock St Ne # 101 in Palm Bay, Florida 32905.

For its online presence, you may visit Oliveira C Mario MD’s website at healthfirstmedicalgroup.org and engage with its social media outlets through on Twitter and on Facebook.